LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Red Wine May Lower Lung Cancer Risk

By LabMedica International staff writers
Posted on 22 Oct 2008
Moderate consumption of red wine may decrease the risk of lung cancer in men, according to a recent report.

"An antioxidant component in red wine may be protective of lung cancer, particularly among smokers,” said Chun Chao, Ph.D., a research scientist at Kaiser Permanente department of research and evaluation (Pasadena, CA, USA).

Dr. Chao analyzed data collected through the California Men's Health Study, which linked clinical data from California's health system with self-reported data from 84,170 men aged 45 to 69 years. Researchers gathered demographics and lifestyle data from surveys computed between 2000 and 2003, and identified 210 cases of lung cancer.

Researchers measured the effect of beer, red wine, white wine, and liquor consumption on the risk of lung cancer. Adjustments were made for age, race/ethnicity, education, income, body mass index, history of chronic obstructive pulmonary disease or emphysema, and smoking history.

Among the study participants, there was on average a 2% lower lung cancer risk associated with each glass of red wine consumed per month. The most considerable risk reduction was among smokers who drank one to two glasses of red wine per day. The researchers reported a 60% reduced lung cancer risk in these men. Researchers cautioned men to stop smoking as the best way to reduce lung cancer risk; noting that even men who drank one to two glasses of red wine per day still face higher lung cancer risk than do non-smokers.

No clear associations with lung cancer were noted for consumption of white wine, beer, or liquor. "Red wine is known to contain high levels of antioxidants. There is a compound called resveratrol that is very rich in red wine because it is derived from the grape skin. This compound has shown significant health benefits in preclinical studies,” Dr. Chao said.

Dr. Chao stressed, however, their findings should not be interpreted as recommending heavy alcohol consumption. His study's findings were the reported in the October 2008 issue of the journal Cancer Epidemiology, Biomarkers, and Prevention.

Related Links:
Kaiser Permanente



New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Hematology Consumables
Bioblood Devices
New
Automated Urinalysis Solution
UN-9000

Latest BioResearch News

Single-Cell Method Measures RNA and Proteins to Reveal Immune Responses
22 Oct 2008  |   BioResearch

Study Links Midlife Vitamin D to Lower Tau in Alzheimer's
22 Oct 2008  |   BioResearch

International Consensus Standardizes Tumor Microbiota Detection and Reporting
22 Oct 2008  |   BioResearch